Limits...
Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.

Kämmer C, Tommasino M, Syrjänen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I - Br. J. Cancer (2002)

Bottom Line: This could partially explain why some lesions progress to cancer while others do not.In addition, we found a specific European E6 variant, L83V, to be enriched in high-grade lesions and cancer rather than a specific European long control region variant.The difference in oncogenicity between European HPV16 genotypes is more probably due to an altered property of the corresponding E6 proteins rather than to an altered activity of the P97 promoter.

View Article: PubMed Central - PubMed

Affiliation: Institute of Virology, University of Cologne, Fürst-Pückler-Strasse 56, D-50935 Cologne, Germany.

Show MeSH

Related in: MedlinePlus

Luciferase expression under the control of the HPV16 LCR-fragments of the different European isolates The results for the isolates US53, 50, 17, 134, 56 and 58 as well as the mutated LCR m-US56 are shown. The mean values of six independent assays together with their standard deviations are demonstrated. The LCR of prototype HPV16 was used as a reference clone and set to the value 1.0 in all assays.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2375181&req=5

fig2: Luciferase expression under the control of the HPV16 LCR-fragments of the different European isolates The results for the isolates US53, 50, 17, 134, 56 and 58 as well as the mutated LCR m-US56 are shown. The mean values of six independent assays together with their standard deviations are demonstrated. The LCR of prototype HPV16 was used as a reference clone and set to the value 1.0 in all assays.

Mentions: The HPV16 LCRs were cloned into the pALuc vector in front of the luciferase gene in order to determine whether the above-mentioned sequence alterations affect the P97 promoter activity. C33A cells were transfected with the isolate constructs and luciferase activities were analyzed 48 h later. All isolates, except US56, exhibited approximately the same activity as the European reference clone with transcription activities ranging from 0.87 to 1.27 (Figure 2Figure 2


Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.

Kämmer C, Tommasino M, Syrjänen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I - Br. J. Cancer (2002)

Luciferase expression under the control of the HPV16 LCR-fragments of the different European isolates The results for the isolates US53, 50, 17, 134, 56 and 58 as well as the mutated LCR m-US56 are shown. The mean values of six independent assays together with their standard deviations are demonstrated. The LCR of prototype HPV16 was used as a reference clone and set to the value 1.0 in all assays.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2375181&req=5

fig2: Luciferase expression under the control of the HPV16 LCR-fragments of the different European isolates The results for the isolates US53, 50, 17, 134, 56 and 58 as well as the mutated LCR m-US56 are shown. The mean values of six independent assays together with their standard deviations are demonstrated. The LCR of prototype HPV16 was used as a reference clone and set to the value 1.0 in all assays.
Mentions: The HPV16 LCRs were cloned into the pALuc vector in front of the luciferase gene in order to determine whether the above-mentioned sequence alterations affect the P97 promoter activity. C33A cells were transfected with the isolate constructs and luciferase activities were analyzed 48 h later. All isolates, except US56, exhibited approximately the same activity as the European reference clone with transcription activities ranging from 0.87 to 1.27 (Figure 2Figure 2

Bottom Line: This could partially explain why some lesions progress to cancer while others do not.In addition, we found a specific European E6 variant, L83V, to be enriched in high-grade lesions and cancer rather than a specific European long control region variant.The difference in oncogenicity between European HPV16 genotypes is more probably due to an altered property of the corresponding E6 proteins rather than to an altered activity of the P97 promoter.

View Article: PubMed Central - PubMed

Affiliation: Institute of Virology, University of Cologne, Fürst-Pückler-Strasse 56, D-50935 Cologne, Germany.

Show MeSH
Related in: MedlinePlus